High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients.
Laursen MB, Reinholdt L, Schönherz AA, Due H, Jespersen DS, Grubach L, Ettrup MS, Røge R, Falgreen S, Sørensen S, Bødker JS, Schmitz A, Johnsen HE, Bøgsted M, Dybkær K.
Laursen MB, et al. Among authors: sorensen s.
Oncotarget. 2019 Jan 22;10(7):717-731. doi: 10.18632/oncotarget.26588. eCollection 2019 Jan 22.
Oncotarget. 2019.
PMID: 30774774
Free PMC article.